Details of the Drug
General Information of Drug (ID: DMA0YYK)
Drug Name |
TABILAUTIDE
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Trimexautide; RP-56142; Tabilautide; N2-[N-(N-Lauroyl-L-alanyl)-gamma-D-glutamyl]-L,L-2,6-diaminopimelamic acid; Threo-6-Carbamoyl-N2-[N-(N-lauroyl-L-alanyl)-D-gamma-glutamyl]-L-lysine; Threo-6-Carboxy-N6-[N-[N-(1-oxodecyl)-L-alanyl]-D-gamma-glutamyl]-L-lysinamide
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL is unavailable | 2D MOL | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||